Narita, Japan

Shigeru Adegawa


Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shigeru Adegawa: Innovator in Pharmaceutical Chemistry

Introduction

Shigeru Adegawa is a notable inventor based in Narita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinolone derivatives. With a total of 3 patents, Adegawa has established himself as a key figure in the development of new pharmaceutical compounds.

Latest Patents

Adegawa's latest patents include "Substituted quinolone derivatives and pharmaceuticals containing the same." These derivatives are represented by a specific formula where R¹ denotes a substituted or unsubstituted (hetero)aryl group, R² represents H or an alkoxycarbonyl, substituted aminocarbonyl, cyano, or similar group, and R³ and R⁴ each independently represent H or a substituted alkyl, aryl, amino, or similar group, along with their salts. These compounds exhibit excellent anti-ulcer activities, showcasing Adegawa's commitment to addressing critical health issues through innovative solutions.

Career Highlights

Throughout his career, Adegawa has worked with various companies, including Ss Pharmaceutical Co., Ltd. and Ssp Co. Ltd. His work in these organizations has allowed him to further his research and development efforts in pharmaceutical chemistry.

Collaborations

Adegawa has collaborated with notable coworkers such as Kazuo Yamazaki and Yoichiro Ogawa. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Shigeru Adegawa's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to impact the development of effective pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…